Ga. Medicaid Program Must Buy Brand-Name Makena: Judge

Law360, New York (August 13, 2012, 1:53 PM EDT) -- A federal judge Thursday ordered Georgia’s Medicaid department to cover bankrupt KV Pharmaceutical Co.’s prenatal medicine Makena despite its relatively high cost, saying the agency’s preference for generics that lack U.S. Food and Drug Administration approval makes regulatory review of drug safety pointless.

U.S. District Judge Charles A. Pannell Jr. acknowledged his preliminary injunction would mean a “drastic cost increase” for taxpayers, as Makena has been priced as high as $1,500 per injection and is now sold for about half that amount, compared with $20 or...
To view the full article, register now.




Case Information

Case Title

Lumara Health, Inc. et al v. Reese et al

Case Number



Georgia Northern

Nature of Suit

Constitutional - State Statute


Charles A. Pannell, Jr

Date Filed

July 17, 2012

Law Firms


Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.